"Empowering Consumer with Smart Devices and Smart Data for Proactive ‘Health Care’" - Maryam Ziaei (Founder/CEO, iSono Health)
Delivered at the inaugural Hyper Wellbeing Summit, 14th November 2016, Mountain View, California.
For more information including details of subsequent events, please visit http://hyperwellbeing.com
The summit was created to foster a community around an emerging industry - Wellness as a Service (WaaS). Consumer technologies, in particular wearables and mobile, are powering a consumer revolution. A revolution to turn health and wellness into platform delivered services. A revolution enabling consumer data-driven disease risk reduction. A revolution extending health care past sick care towards consumer-led lifelong health, wellness and lifestyle optimization.
WaaS newsletter sign-up http://eepurl.com/b71fdr
@hyperwellbeing
22. Intelligent Information Management
• Longitudinal data
– Personal baseline
– Detect trends & deviations from norm
• Personal health records
– Privacy
– Sharing
– Anonymous aggregation
• Patient-centered decision support
34. 47% of women have dense breasts
BUT Mammogram misses tumors in
dense breasts
Breast Cancer screening
is sporadic, inaccessible, and expensive
High risk women need more regular
screening
35. Current Breast Ultrasound
Sources: American Cancer Society, American College of Radiology
Image Quality is
Operator Dependent
False Positive
36. Cost ~ 5-10K
SonoSite PhilipsGE VSCAN
GE Siemens
Cost ~ $200-400K
35.7% More Cancer Detected with
Automated Breast Ultrasound *
Point-of-Care
Automated
42. Early Adopters
Market of $4B
CAGR of 10.8% Pricing:
$300/Device
$20/User/M
onth ARR
US Market
8.6M
Women at
Very High
Risk
Total
Addressable
Market of $32B
102M
Women over
30 in US
43. Early Stage
Diagnosis
$20K pp
Late Stage
Diagnosis
$100-300K pp
$18.5B Direct Cost of Breast Cancer
+
$14B Lost Productivity Per Year
for self-insured employers and health
insurance companies
Why Would Payers Care?
46. Making Sense of Big Data
• Understanding human behavior from sensor data
– Integrating vastly different kinds of data
– Incorporating commonsense knowledge
– Compute intensive methods for learning & inference
• Embedded, mobile, and distributed systems
– Data transport in dynamic, heterogeneous environments
– Security and data sharing
– Data / annotation / interpretation streams
47.
48.
49. 49
System Concept
Personal Health Monitoring
• Preventative Healthcare
• Chronic Care Management
• Post-surgery Monitoring
• Borrow from the field of machine
health monitoring
– Identify the most minimally invasive ways to capture data
– Mine collected data to identify personal baselines, data
defined models and track changes
– Identify patient preferences and create a system that gives
a valuable user experience
– Identify effective ways to share data with health care
providers
Measure
• Cardiac function (ECG)
• Respiration (Sound/ECG)
• Activity (Accelerometry) Alivetec ECG & motionTouch screen
mobile phone
50. Personal Health Management Assistant
• Provide effective, intuitive access to
information in Personal Health Record
• True conversational interaction
– UR Computer Science leading center of research
on dialog systems
– Not just canned responses: reasons about user
model and dialog context
• Target population: Heart failure patients
following self-care guidelines
– Collect information relevant to condition
– Interpret with respect to self-care guidelines
– Suggest appropriate course of action
– Facilitate information sharing with doctors &
family
53. Go-to-Market Strategy
High Risk
Women
Surveillance
Women over
30
Screening
Channels
&
Partners
• Women Healthcare
Centers
• BC Advocacy
Groups
• Genetic
Testing/Counseling
• Corporate Wellness
• Mail-in-Subscription
• Walk-in Health Clinics
Breast Cancer
Patient
Monitoring
• Breast Cancer
Centers
• BC Pharma
54. 1Billion Women
need additional
screening
50M Women at
Very High Risk
due to Family
History or
Genetics
Every Year 1.7M New Cases of Breast Cancer
Market
Over 500,000 Breast Cancer Deaths/year
56. 1Billion Women
over 30 in the
World with
Dense Breasts
50M Women at
Very High Risk
due to Family
History or
Genetics
Every Year 1.7M New Cases of Breast Cancer
Market
Over 500,000 Breast Cancer Deaths/year
57. Early Adopters
Market of $4B
CAGR of 10.8% Pricing:
$300/Device
$20/User/M
onth ARR
US Market
8.6M
Women at
Very High
Risk
Total
Addressable
Market of $32B
102M
Women over
30 in US
58. European Market
Every Year 500,000 New Cases of Breast Cancer
Over 140,000 Breast Cancer Deaths/year
14M Women at
Very High Risk due
to Family History or
Genetics
Early Adopters
Market of $8B
60. Current Breast Cancer Screening
Self Breast Exam
Ineffective for small
tumors
Mammogram
Low Sensitivity
X-ray Radiation
61. 1Billion Women
over 30 in the
World with
Dense Breasts
50M Women at
Very High Risk
due to Family
History or
Genetics
Every Year 1.7M New Cases of Breast Cancer
Global Market
Over 500,000 Breast Cancer Deaths/year
62. Quantitative Ultrasound + Machine Learning
• A multi-parameter longitudinal approach improves
precision
Grayscale Image
Qualitative
features
• Shape
• Contour
• Shadow
Raw RF signal
Quantitative features
• Power spectrum
• Statistics
• Frequency
dependence
Parametric Change
Longitudinal features
• Volume density
• Cell death/growth
• Tissue acoustic
properties
63. FDA Regulatory Roadmap
Research and
Development
Pre-Clinical
Development
Clinical
Testing
FDA 510(k)
Approval
Concept
Design Control
Design
Iterations
Repeatability
Testing
Submit 510(k)
Package
FDA Review
& QuestionsPackaging &
Labeling
Biocompatability
Repeatability
Testing
Electrical &
Mechanical
Testing
Repeatability
Testing
IRB/IDE
Approval
Neo-adjuvant
Chemo Trial
12weeks
~100 Patients
Human
Factor Study
~50-75
Users
Efficacy
Best Case Scenario:
Class II 510(k) no clinical study
• Predicate found already
• Expected clearance 5-6mo
• Need 50 users for usability
Validation Development
Worst Case Scenario:
Class II 510(k) DeNovo
- Expected clearance 10-
12mo
- Need 100+ users for clinical
Efficacy
We’re
Here
66. Partnerships
iSono Health’s compact, low-cost, automated ultrasound system
enables Remote Patient Monitoring for:
Neoadjuvent
Chemo
Patients, BC
Clinical Trials
Tracking Response to
Treatment
Personalized
Treatment
Early Stage BC
Patient
Post-Lumpectomy
Recurrence
Monitoring
Breast Conserving
Surgeries
High Risk
Women with
Family History,
Genetics
Surveillance Early Stage Detection
Healthy
Women with
Dense Breasts
Supplemental
Screening
False-
Negative/Positive
Reduction
67. Customer Validation
In a national survey of 1000
women, 38% have responded
favorably to purchasing our
device
"Amazing idea. Anything that
can give anyone a more
sound piece of mind or the
ability to see something
sooner is a great tool."
"Please keep me informed of
the details of this product."
"I'm very excited about this
being a viable option for
preventative screening!"
"I would be excited to have
access to a device like this. I
live in a rural area with little
access to Healthcare. I have
been diagnosed with BRCA1
mutated gene … this would
help me be proactive."
68% of high-risk women self-
reported as “very/extremely
willing” to purchase our
device
68. Device
Machine
LearningCloud
iSono IP Strategy
- Array Architecture
Transducer Assembly
- 3D Image Processing
-Tag and Measure
Breast Masses
-Track changes over
time
- User Interface
- Scan Analytics
- Genetic + Scan
Actionable
69. Cost ~ 5-10K
Current Ultrasound Trends: Cheaper, Automated
SonoSite PhilipsGE VSCAN MobiSante
Image Quality is
Operator DependentGE Invenia
(Acquired U Systems)
Siemens
ACUSON S2000
SonoCine
Cost ~ $200-400K
35.7% More Cancer Detected with Automated Breast Ultrasound*
Compact Ultrasound Probe Systems
Sources: MarketsandMarkets, Frost and Sullivan
*http://www.fdanews.com/articles/164936-ge-healthcare-nabs-fda-approval-of-invenia-abus-breast-imaging-technology
70. How Does it Work?
Comfortably wear
the bra accessory.
Attach scanner to ring
on either breast.
Open iSono app
press “scan.”
The scan completes in
1 minute.
Attach device to
the second ring on
the other breast.
Our software will
process images and
tag any changes.
Physician receives your
tagged images & sends
you feedback via the app.
The app will remind
you of the next scan
in 1 month.
71. Real Time Data
Real Time Feedback
Faster Return to Work
Less time in hospital/healthcare facilities reduced cost
Post surgery monitoring
Notas do Editor
1 in 3 breast cancers are missed at early stage by current screening methods.
1 in 3 breast cancers are missed at early stage by current screening methods.
1 in 3 breast cancers are missed at early stage by current screening methods.
1 in 3 breast cancers are missed at early stage by current screening methods.
Opportunities with consumer-based home healthcare devices
Connected devices
Transform big data into information that delivers insights
Simply user experience with Human-centered design
Opportunities with consumer-based home healthcare devices
Connected devices
Transform big data into information that delivers insights
Simply user experience with Human-centered design
Opportunities with consumer-based home healthcare devices
Connected devices
Transform big data into information that delivers insights
Simply user experience with Human-centered design
Opportunities with consumer-based home healthcare devices
Connected devices
Transform big data into information that delivers insights
Simply user experience with Human-centered design
Opportunities with consumer-based home healthcare devices
Connected devices
Transform big data into information that delivers insights
Simply user experience with Human-centered design
Opportunities with consumer-based home healthcare devices
Connected devices
Transform big data into information that delivers insights
Simply user experience with Human-centered design
Opportunities with consumer-based home healthcare devices
Connected devices
Transform big data into information that delivers insights
Simply user experience with Human-centered design
Opportunities with consumer-based home healthcare devices
Connected devices
Transform big data into information that delivers insights
Simply user experience with Human-centered design
Opportunities with consumer-based home healthcare devices
Connected devices
Transform big data into information that delivers insights
Simply user experience with Human-centered design
1 in 3 breast cancers are missed at early stage by current screening methods.
1 in 3 breast cancers are missed at early stage by current screening methods.
1 in 3 breast cancers are missed at early stage by current screening methods.
Hi, I’m Maryam, co-founder of iSono health, we have developed a platform to empower every woman to take charge of their own health with a connected breast health monitoring platform
Our platform combined automated ultrasound technology with Artificial Intelligence and Cloud Computation to regularly monitoring and tracking breast health over time, for early detection of breast cancer.
When I was in college my friend Kelly was diagnosed with breast cancer. She wasn’t even 30…She was lucky her cancer was caught at early stage and after treatment now she’s healthy and has a kind. Every year 1.7 Million women get diagnosed globally with breast cancer, 500,000 here europe. Many of them are not as lucky.
1 in 3 breast cancers are missed at early stage by current screening methods.
You might ask why? That’s because nearly half of women half dense tissues in their breast that makes mammogram ineffective. On the top right here you can see how a dense breast looks like in a mammogram, it effectively masks any small tumors.
A great alternative to mammogram is Ultrasound. However ultrasound is not used today as screening tool, b/c it’s slow, images are operator dependent and has high false positives.
Beyond that women who are at high risk of breast cancer due to family history or genetics need more regular screening but breast cancer screening today is only once a year, its expensive and inconvenient.
we are making a disruption by making it lower cost and bring it in the hand of consumer
Regular monitoring
Smartphones and other personal mobile devices are one of the main drivers as to why the consumer health monitoring device market will grow, the research report states. According to IMS, there is a wealth of mobile health apps, allowing users to transfer readings from a medical device, which can then be stored and displayed on the device, or uploaded to a cloud-based system. This is possible, the researchers say, by buying independent devices from companies such as A&D Medical which utilize wireless technologies such as ANT+ or Bluetooth. Measurements from these devices can be viewed and stored locally, on devices such as smart phones, or uploaded to independent cloud-based systems.
“Many consumers already utilize smartphone apps to track their own health and fitness results, with devices such as activity monitors and heart-rate monitors. Now, there is increasing availability of health-related peripheral devices such as blood pressure monitors to track and upload information in real time via a wireless or wired connection to devices such as smartphones and tablets,” Arrowsmith says.
The report looks at 10 connectivity technologies in five consumer health monitoring devices, five types of dedicated health hub (with addition segmentation between managed telehealth devices and consumer medical devices), and five sports and fitness monitoring devices.
Around the World:
Nearly 1.7 million new breast cancer cases were diagnosed in 2012.
Breast cancer is the second most common cancer in women and men worldwide. In 2012, it represented about 12 percent of all new cancer cases and 25 percent of all cancers in women.
Breast cancer is the most frequently diagnosed cancer among women in 140 of 184 countries worldwide.
Globally, breast cancer now represents one in four of all cancers in women.
Since 2008, worldwide breast cancer incidence has increased by more than 20 percent. Mortality has increased by 14 percent.According to the World Cancer Research Fund International
Smartphones and other personal mobile devices are one of the main drivers as to why the consumer health monitoring device market will grow, the research report states. According to IMS, there is a wealth of mobile health apps, allowing users to transfer readings from a medical device, which can then be stored and displayed on the device, or uploaded to a cloud-based system. This is possible, the researchers say, by buying independent devices from companies such as A&D Medical which utilize wireless technologies such as ANT+ or Bluetooth. Measurements from these devices can be viewed and stored locally, on devices such as smart phones, or uploaded to independent cloud-based systems.
“Many consumers already utilize smartphone apps to track their own health and fitness results, with devices such as activity monitors and heart-rate monitors. Now, there is increasing availability of health-related peripheral devices such as blood pressure monitors to track and upload information in real time via a wireless or wired connection to devices such as smartphones and tablets,” Arrowsmith says.
The report looks at 10 connectivity technologies in five consumer health monitoring devices, five types of dedicated health hub (with addition segmentation between managed telehealth devices and consumer medical devices), and five sports and fitness monitoring devices.
Around the World:
Nearly 1.7 million new breast cancer cases were diagnosed in 2012.
Breast cancer is the second most common cancer in women and men worldwide. In 2012, it represented about 12 percent of all new cancer cases and 25 percent of all cancers in women.
Breast cancer is the most frequently diagnosed cancer among women in 140 of 184 countries worldwide.
Globally, breast cancer now represents one in four of all cancers in women.
Since 2008, worldwide breast cancer incidence has increased by more than 20 percent. Mortality has increased by 14 percent.According to the World Cancer Research Fund International
Breast Cancer has likely affected everyone in this room one way and another.
We want to make sure no woman dies from breast cancer and put the power back into the hands of consumer.
WE have the smart technology to do this
Come see a demo and join us to save lives.
1 in 3 breast cancers are missed at early stage by current screening methods.
1 in 3 breast cancers are missed at early stage by current screening methods.
1 in 3 breast cancers are missed at early stage by current screening methods.
1 in 3 breast cancers are missed at early stage by current screening methods.
1 in 3 breast cancers are missed at early stage by current screening methods.
Smartphones and other personal mobile devices are one of the main drivers as to why the consumer health monitoring device market will grow, the research report states. According to IMS, there is a wealth of mobile health apps, allowing users to transfer readings from a medical device, which can then be stored and displayed on the device, or uploaded to a cloud-based system. This is possible, the researchers say, by buying independent devices from companies such as A&D Medical which utilize wireless technologies such as ANT+ or Bluetooth. Measurements from these devices can be viewed and stored locally, on devices such as smart phones, or uploaded to independent cloud-based systems.
“Many consumers already utilize smartphone apps to track their own health and fitness results, with devices such as activity monitors and heart-rate monitors. Now, there is increasing availability of health-related peripheral devices such as blood pressure monitors to track and upload information in real time via a wireless or wired connection to devices such as smartphones and tablets,” Arrowsmith says.
The report looks at 10 connectivity technologies in five consumer health monitoring devices, five types of dedicated health hub (with addition segmentation between managed telehealth devices and consumer medical devices), and five sports and fitness monitoring devices.
Around the World:
Nearly 1.7 million new breast cancer cases were diagnosed in 2012.
Breast cancer is the second most common cancer in women and men worldwide. In 2012, it represented about 12 percent of all new cancer cases and 25 percent of all cancers in women.
Breast cancer is the most frequently diagnosed cancer among women in 140 of 184 countries worldwide.
Globally, breast cancer now represents one in four of all cancers in women.
Since 2008, worldwide breast cancer incidence has increased by more than 20 percent. Mortality has increased by 14 percent.According to the World Cancer Research Fund International
Wearable medical devices defined in the strictest sense are devices with sensors attached to the body that detect and monitor changes in body signatures of various areas and organs. This report focuses on the various segments of wearable devices currently available in the market and also predicts the introduction of several innovative devices in the future.
http://www.transparencymarketresearch.com/wearable-medical-devices.html
Smartphones and other personal mobile devices are one of the main drivers as to why the consumer health monitoring device market will grow, the research report states. According to IMS, there is a wealth of mobile health apps, allowing users to transfer readings from a medical device, which can then be stored and displayed on the device, or uploaded to a cloud-based system. This is possible, the researchers say, by buying independent devices from companies such as A&D Medical which utilize wireless technologies such as ANT+ or Bluetooth. Measurements from these devices can be viewed and stored locally, on devices such as smart phones, or uploaded to independent cloud-based systems.
“Many consumers already utilize smartphone apps to track their own health and fitness results, with devices such as activity monitors and heart-rate monitors. Now, there is increasing availability of health-related peripheral devices such as blood pressure monitors to track and upload information in real time via a wireless or wired connection to devices such as smartphones and tablets,” Arrowsmith says.
The report looks at 10 connectivity technologies in five consumer health monitoring devices, five types of dedicated health hub (with addition segmentation between managed telehealth devices and consumer medical devices), and five sports and fitness monitoring devices.
Around the World:
Nearly 1.7 million new breast cancer cases were diagnosed in 2012.
Breast cancer is the second most common cancer in women and men worldwide. In 2012, it represented about 12 percent of all new cancer cases and 25 percent of all cancers in women.
Breast cancer is the most frequently diagnosed cancer among women in 140 of 184 countries worldwide.
Globally, breast cancer now represents one in four of all cancers in women.
Since 2008, worldwide breast cancer incidence has increased by more than 20 percent. Mortality has increased by 14 percent.According to the World Cancer Research Fund International
Smartphones and other personal mobile devices are one of the main drivers as to why the consumer health monitoring device market will grow, the research report states. According to IMS, there is a wealth of mobile health apps, allowing users to transfer readings from a medical device, which can then be stored and displayed on the device, or uploaded to a cloud-based system. This is possible, the researchers say, by buying independent devices from companies such as A&D Medical which utilize wireless technologies such as ANT+ or Bluetooth. Measurements from these devices can be viewed and stored locally, on devices such as smart phones, or uploaded to independent cloud-based systems.
“Many consumers already utilize smartphone apps to track their own health and fitness results, with devices such as activity monitors and heart-rate monitors. Now, there is increasing availability of health-related peripheral devices such as blood pressure monitors to track and upload information in real time via a wireless or wired connection to devices such as smartphones and tablets,” Arrowsmith says.
The report looks at 10 connectivity technologies in five consumer health monitoring devices, five types of dedicated health hub (with addition segmentation between managed telehealth devices and consumer medical devices), and five sports and fitness monitoring devices.
Around the World:
Nearly 1.7 million new breast cancer cases were diagnosed in 2012.
Breast cancer is the second most common cancer in women and men worldwide. In 2012, it represented about 12 percent of all new cancer cases and 25 percent of all cancers in women.
Breast cancer is the most frequently diagnosed cancer among women in 140 of 184 countries worldwide.
Globally, breast cancer now represents one in four of all cancers in women.
Since 2008, worldwide breast cancer incidence has increased by more than 20 percent. Mortality has increased by 14 percent.According to the World Cancer Research Fund International
Smartphones and other personal mobile devices are one of the main drivers as to why the consumer health monitoring device market will grow, the research report states. According to IMS, there is a wealth of mobile health apps, allowing users to transfer readings from a medical device, which can then be stored and displayed on the device, or uploaded to a cloud-based system. This is possible, the researchers say, by buying independent devices from companies such as A&D Medical which utilize wireless technologies such as ANT+ or Bluetooth. Measurements from these devices can be viewed and stored locally, on devices such as smart phones, or uploaded to independent cloud-based systems.
“Many consumers already utilize smartphone apps to track their own health and fitness results, with devices such as activity monitors and heart-rate monitors. Now, there is increasing availability of health-related peripheral devices such as blood pressure monitors to track and upload information in real time via a wireless or wired connection to devices such as smartphones and tablets,” Arrowsmith says.
The report looks at 10 connectivity technologies in five consumer health monitoring devices, five types of dedicated health hub (with addition segmentation between managed telehealth devices and consumer medical devices), and five sports and fitness monitoring devices.
Around the World:
Nearly 1.7 million new breast cancer cases were diagnosed in 2012.
Breast cancer is the second most common cancer in women and men worldwide. In 2012, it represented about 12 percent of all new cancer cases and 25 percent of all cancers in women.
Breast cancer is the most frequently diagnosed cancer among women in 140 of 184 countries worldwide.
Globally, breast cancer now represents one in four of all cancers in women.
Since 2008, worldwide breast cancer incidence has increased by more than 20 percent. Mortality has increased by 14 percent.According to the World Cancer Research Fund International
You might ask why? That’s because screening is sporadic and inaccessible to millions of women worldwide. And among those who have access to screening, mammogram doesn’t work for half of women who have dense breasts due to to limitations of xray technology. Furthermore, women who have family history or genetically predisposed need even more frequent screening. These three groups of women consitute our different costumer segments.
A great alternative to mammogram is Ultrasound. However ultrasound is not used today as screening tool, b/c it’s slow, images are operator dependent and has high false positives.
Beyond that women who are at high risk of breast cancer due to family history or genetics need more regular screening but breast cancer screening today is only once a year, its expensive and inconvenient.
1 in 8 women will be diagnosed with invasive breast cancer in their lifetime
Every 3 minutes a woman is diasnosed with breast cancer
Every 13 minutes a woman dies from breast cancer
>400,000 Deaths per year from Breast Cancer
Early detection can increase the 10 year survival rate to 97%
Mammogram, which is the primary screening tool, cannot detect cancer in dense breast tissue (~50% of women)
Insurance cover mammogram screening for women above 50
Women with high risk have 60-80% chance of breast cancer require regular monitoring
If you have a first degree relative who was diagnosed with breast cancer your chances are two times higher. If you have two relatives who were diagnosed, your chances are 5x higher
Some women with high risk such as Angelina Jolie resort to double-mastectomy
Even with double mastectomy, you have to constantly monitor your breast/breast area as cancerous cell still can develop
Smartphones and other personal mobile devices are one of the main drivers as to why the consumer health monitoring device market will grow, the research report states. According to IMS, there is a wealth of mobile health apps, allowing users to transfer readings from a medical device, which can then be stored and displayed on the device, or uploaded to a cloud-based system. This is possible, the researchers say, by buying independent devices from companies such as A&D Medical which utilize wireless technologies such as ANT+ or Bluetooth. Measurements from these devices can be viewed and stored locally, on devices such as smart phones, or uploaded to independent cloud-based systems.
“Many consumers already utilize smartphone apps to track their own health and fitness results, with devices such as activity monitors and heart-rate monitors. Now, there is increasing availability of health-related peripheral devices such as blood pressure monitors to track and upload information in real time via a wireless or wired connection to devices such as smartphones and tablets,” Arrowsmith says.
The report looks at 10 connectivity technologies in five consumer health monitoring devices, five types of dedicated health hub (with addition segmentation between managed telehealth devices and consumer medical devices), and five sports and fitness monitoring devices.
Around the World:
Nearly 1.7 million new breast cancer cases were diagnosed in 2012.
Breast cancer is the second most common cancer in women and men worldwide. In 2012, it represented about 12 percent of all new cancer cases and 25 percent of all cancers in women.
Breast cancer is the most frequently diagnosed cancer among women in 140 of 184 countries worldwide.
Globally, breast cancer now represents one in four of all cancers in women.
Since 2008, worldwide breast cancer incidence has increased by more than 20 percent. Mortality has increased by 14 percent.According to the World Cancer Research Fund International
1 in 8 women will be diagnosed with invasive breast cancer in their lifetime
Every 3 minutes a woman is diasnosed with breast cancer
Every 13 minutes a woman dies from breast cancer
>400,000 Deaths per year from Breast Cancer
Early detection can increase the 10 year survival rate to 97%
Mammogram, which is the primary screening tool, cannot detect cancer in dense breast tissue (~50% of women)
Insurance cover mammogram screening for women above 50
Women with high risk have 60-80% chance of breast cancer require regular monitoring
If you have a first degree relative who was diagnosed with breast cancer your chances are two times higher. If you have two relatives who were diagnosed, your chances are 5x higher
Some women with high risk such as Angelina Jolie resort to double-mastectomy
Even with double mastectomy, you have to constantly monitor your breast/breast area as cancerous cell still can develop
----- Meeting Notes (10/19/16 14:52) -----
insurance
Change colors of arrows
1 in 3 breast cancers are missed at early stage by current screening methods.